The U.S. Food and Drug Administration approved Johnson & Johnson’s drug Darzalex Faspro as the first treatment for adults with high-risk smoldering multiple myeloma, a precursor to the blood cancer.

Harbour BioMed, a global biopharmaceutical company, and Evinova, a global health-tech company, have entered a strategic ...

Argonaut Manufacturing Services, a contract development manufacturing organization (CDMO) specializing in aseptic drug product manufacturing and the manufacturing of life science and diagnostic ...

Cytiva has launched the fibro dT platform for mRNA capture and purification processes.

Abzena, an integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on developing fully human antibodies, formed a strategic partnership.

Alvotech and Advanz Pharma Receive Marketing Authorizations for Gobivaz, a Biosimilar to Simponi (golimumab), from the MHRA.

Biovectra and Revolution Biomanufacturing have announced a collaboration that grants Biovectra access to Revolution Biomanufacturing's proprietary platforms to enhance mRNA stability and translational ...

Optimer binders against three therapeutic targets to support drug validation and potential clinical trial applications ...

Touchlight has expanded its mbDNA platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA.

Kuvalanka brings over 20 years of experience in biopharmaceutical leadership, including finance, business development, and corporate strategy.

Agreement includes approximately $350 million in cash and upfront technology license fees for Evotec’s continuous manufacturing platform.

Ailux has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of bispecific antibodies.